NZ329853A - 4-piperidinyl substituted 2-amino indane derivatives and medicaments - Google Patents
4-piperidinyl substituted 2-amino indane derivatives and medicamentsInfo
- Publication number
- NZ329853A NZ329853A NZ329853A NZ32985398A NZ329853A NZ 329853 A NZ329853 A NZ 329853A NZ 329853 A NZ329853 A NZ 329853A NZ 32985398 A NZ32985398 A NZ 32985398A NZ 329853 A NZ329853 A NZ 329853A
- Authority
- NZ
- New Zealand
- Prior art keywords
- alkyl
- medicaments
- indane derivatives
- piperidinyl substituted
- amino indane
- Prior art date
Links
- LMHHFZAXSANGGM-UHFFFAOYSA-N 2-aminoindane Chemical class C1=CC=C2CC(N)CC2=C1 LMHHFZAXSANGGM-UHFFFAOYSA-N 0.000 title abstract 2
- 239000003814 drug Chemical class 0.000 title 1
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 4
- 125000000623 heterocyclic group Chemical group 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 229910052799 carbon Inorganic materials 0.000 abstract 1
- 125000004432 carbon atom Chemical group C* 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 125000004433 nitrogen atom Chemical group N* 0.000 abstract 1
- 230000003287 optical effect Effects 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 125000004430 oxygen atom Chemical group O* 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D411/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
- C07D411/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D411/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Pain & Pain Management (AREA)
- Child & Adolescent Psychology (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9702360A FR2760014B1 (fr) | 1997-02-27 | 1997-02-27 | Nouveaux composes de 2-amino indane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NZ329853A true NZ329853A (en) | 1999-01-28 |
Family
ID=9504253
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NZ329853A NZ329853A (en) | 1997-02-27 | 1998-02-26 | 4-piperidinyl substituted 2-amino indane derivatives and medicaments |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US5968954A (https=) |
| EP (1) | EP0861837B1 (https=) |
| JP (1) | JPH10237071A (https=) |
| CN (1) | CN1090627C (https=) |
| AT (1) | ATE265451T1 (https=) |
| AU (1) | AU725756B2 (https=) |
| BR (1) | BR9800763A (https=) |
| CA (1) | CA2231025C (https=) |
| DE (1) | DE69823411T2 (https=) |
| DK (1) | DK0861837T3 (https=) |
| ES (1) | ES2219853T3 (https=) |
| FR (1) | FR2760014B1 (https=) |
| HU (1) | HU224312B1 (https=) |
| NO (1) | NO314307B1 (https=) |
| NZ (1) | NZ329853A (https=) |
| PL (1) | PL190240B1 (https=) |
| PT (1) | PT861837E (https=) |
| ZA (1) | ZA981680B (https=) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI274750B (en) | 1999-01-12 | 2007-03-01 | Abbott Gmbh & Co Kg | Triazole compounds showing high affinity to dopamine D3 receptor and pharmaceutical composition comprising the same |
| SE0103650D0 (sv) * | 2001-11-01 | 2001-11-01 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
| NZ535574A (en) * | 2001-01-16 | 2006-07-28 | Astrazeneca Ab | Therapeutic heterocyclic compounds |
| ATE424825T1 (de) | 2001-07-20 | 2009-03-15 | Psychogenics Inc | Behandlung von hyperaktivitätsstörungen und aufmerksamkeitsdefiziten |
| JP2005343790A (ja) * | 2002-05-31 | 2005-12-15 | Ajinomoto Co Inc | カルシウムチャネル拮抗薬を含有する医薬組成物 |
| US20050165025A1 (en) * | 2004-01-22 | 2005-07-28 | Recordati Ireland Ltd. | Combination therapy with 5HT 1A and 5HT 1B-receptor antagonists |
| CA2587749A1 (en) * | 2004-12-08 | 2006-06-15 | Astellas Pharma Inc. | Piperidine derivative and process for producing the same |
| UY29892A1 (es) * | 2005-11-04 | 2007-06-29 | Astrazeneca Ab | Nuevos derivados de cromano, composiciones farmaceuticas conteniendolos, procesos de preparacion y aplicaciones |
| WO2020183011A1 (en) | 2019-03-14 | 2020-09-17 | Institut Curie | Htr1d inhibitors and uses thereof in the treatment of cancer |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9318431D0 (en) * | 1993-09-06 | 1993-10-20 | Boots Co Plc | Therapeutic agents |
| FR2734819B1 (fr) * | 1995-05-31 | 1997-07-04 | Adir | Nouveaux composes de la piperazine, de la piperidine et de la 1,2,5,6-tetrahydropyridine, leur procede de preparation et les compositions pharmaceutiques les contenant |
-
1997
- 1997-02-27 FR FR9702360A patent/FR2760014B1/fr not_active Expired - Fee Related
-
1998
- 1998-02-24 PL PL98324982A patent/PL190240B1/pl not_active IP Right Cessation
- 1998-02-25 JP JP10042716A patent/JPH10237071A/ja active Pending
- 1998-02-25 BR BR9800763-7A patent/BR9800763A/pt not_active Application Discontinuation
- 1998-02-26 HU HU9800422A patent/HU224312B1/hu not_active IP Right Cessation
- 1998-02-26 US US09/031,490 patent/US5968954A/en not_active Expired - Fee Related
- 1998-02-26 CN CN98107709A patent/CN1090627C/zh not_active Expired - Fee Related
- 1998-02-26 CA CA002231025A patent/CA2231025C/fr not_active Expired - Fee Related
- 1998-02-26 NO NO19980803A patent/NO314307B1/no unknown
- 1998-02-26 NZ NZ329853A patent/NZ329853A/xx unknown
- 1998-02-27 ES ES98400469T patent/ES2219853T3/es not_active Expired - Lifetime
- 1998-02-27 AT AT98400469T patent/ATE265451T1/de not_active IP Right Cessation
- 1998-02-27 DK DK98400469T patent/DK0861837T3/da active
- 1998-02-27 EP EP98400469A patent/EP0861837B1/fr not_active Expired - Lifetime
- 1998-02-27 ZA ZA981680A patent/ZA981680B/xx unknown
- 1998-02-27 PT PT98400469T patent/PT861837E/pt unknown
- 1998-02-27 AU AU56359/98A patent/AU725756B2/en not_active Ceased
- 1998-02-27 DE DE69823411T patent/DE69823411T2/de not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT861837E (pt) | 2004-07-30 |
| FR2760014A1 (fr) | 1998-08-28 |
| BR9800763A (pt) | 1999-12-07 |
| CN1194983A (zh) | 1998-10-07 |
| NO980803L (no) | 1998-08-28 |
| NO980803D0 (no) | 1998-02-26 |
| CA2231025C (fr) | 2003-09-16 |
| DK0861837T3 (da) | 2004-08-16 |
| HU224312B1 (hu) | 2005-07-28 |
| FR2760014B1 (fr) | 1999-04-09 |
| EP0861837B1 (fr) | 2004-04-28 |
| PL324982A1 (en) | 1998-08-31 |
| HUP9800422A1 (hu) | 1999-12-28 |
| DE69823411T2 (de) | 2005-02-17 |
| DE69823411D1 (de) | 2004-06-03 |
| CN1090627C (zh) | 2002-09-11 |
| US5968954A (en) | 1999-10-19 |
| ES2219853T3 (es) | 2004-12-01 |
| HU9800422D0 (en) | 1998-04-28 |
| PL190240B1 (pl) | 2005-11-30 |
| JPH10237071A (ja) | 1998-09-08 |
| CA2231025A1 (fr) | 1998-08-27 |
| HK1014945A1 (en) | 1999-10-08 |
| EP0861837A1 (fr) | 1998-09-02 |
| NO314307B1 (no) | 2003-03-03 |
| AU725756B2 (en) | 2000-10-19 |
| ATE265451T1 (de) | 2004-05-15 |
| ZA981680B (en) | 1998-09-04 |
| AU5635998A (en) | 1998-09-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| FR2654104B1 (fr) | Nouveaux derives du 1,2-benzisoxazole, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent. | |
| MY119150A (en) | Azetidine derivatives, their preparation and medicaments containing them | |
| BR9803295A (pt) | preparos e composições farmacêuticas contendo os mesmos. | |
| GB9115377D0 (en) | New compositions of matter | |
| ATE185792T1 (de) | Stilbenderivate und diese enthaltende pharmazeutische zusammensetzungen | |
| DK0562956T3 (da) | Hidtil ukendte naphthylalkylaminer, fremgangsmåde til fremstilling heraf og farmaceutiske midler, som indeholder dem | |
| ES2091834T3 (es) | Compuestos aromaticos. | |
| GR3033996T3 (en) | 3-(Piperi-4-yl) 1,2-benzisoxazole and 3-(piperazin-4-yl) 1,2-benzisoxazole derivatives, processes for their preparation and pharmaceutical compositions containing them | |
| ATE226574T1 (de) | 4,6-diarylpyrimidin-derivate und deren salze | |
| FI915970A0 (fi) | Laekemedel, som aer nyttiga vid vaord av cancer och som har antihistaminegenskaper. | |
| ES2093332T3 (es) | Nuevos derivados arilglicinamidicos, su procedimiento de preparacion y su uso para el tratamiento de la disuria. | |
| NZ329853A (en) | 4-piperidinyl substituted 2-amino indane derivatives and medicaments | |
| CA2251003A1 (fr) | Nouveaux composes derives de n-aryl 2-hydroxy alkylamides | |
| HRP20000508B9 (hr) | Supstituirani 2-benzilamino-2-fenil-acetamidni spojevi | |
| NO975121D0 (no) | Nye heterocykliske aminometylforbindelser, fremgangsmåte ved fremstilling av dem og farmasöytiske sammensetninger som inneholder dem | |
| ZA964842B (en) | Indole indazole and benzisoxazole compounds their process of preparation and the pharmaceutical compositions which contain them | |
| MX9205921A (es) | Derivados de bis(fenil)etano, proceso para su preparacion y composicion farmaceutica que los contiene | |
| ATE275133T1 (de) | 1,2-dihydro-2-oxochinolin-derivate | |
| IL116386A0 (en) | Use of 1,2 bridged 1,4 dihydropyridines and process for their prepration | |
| ES2065192T3 (es) | Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen. | |
| ES2143159T3 (es) | Nuevos derivados de 2-ciano-3-hidroxi-propenamidas que comprenden un radical trifluorometilsulfonilfenilo/trifluorometilsulfinilfenilo, procedimiento de preparacion, aplicacion como medicamentos y composiciones farmaceuticas que los contienen. | |
| DK0635011T3 (da) | Hydrazid-derivater af 3,4-dihydro-2H-1-benzopyraner | |
| FI933928A0 (fi) | Heteroarenylpiperaziner, foerfarande foer framstaellning av dessa och anvaendning som laekemedel | |
| ATE284402T1 (de) | Pyrroloindol-derivate und zwischenprodukte zu ihrer herstellung | |
| MX9801963A (es) | Derivados de benzotiazolona. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RENW | Renewal (renewal fees accepted) | ||
| ASS | Change of ownership |
Owner name: LES LABORATOIRES SERVIER, FR Free format text: OLD OWNER(S): ADIR ET COMPAGNIE |
|
| RENW | Renewal (renewal fees accepted) |